Search

everythinglearnresearchcommunity

for

Search:↓

A genetic defect in an Appenzeller Mountain Dog caused skin issues, improved with ketoconazole, showing the importance of advanced genetic testing.

WNT10A gene mutations cause short anagen hair syndrome.

A genetic mutation in the DCAF17 gene caused Woodhouse-Sakati syndrome in a Chinese patient from a related family.

A new technology showed that the SOX9 gene might control heart scar formation after injury, suggesting new treatment possibilities.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

IGN genes may regulate hair growth and could be targeted for hair-loss treatments.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Non-viral delivery systems and stimuli-responsive nanoformulations can improve CRISPR-Cas9 gene therapy.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Epiprofin suppresses parathyroid hormone gene activity, helping regulate calcium levels and could be a treatment target for hyperparathyroidism.

Effective PCOS treatments require targeting specific signaling pathways.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Young donor, early passage stem cells have the highest stemness.

Tadalafil and Finasteride may help treat aggressive melanoma.

LncRNAs may help improve brain cancer treatment and diagnosis.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

ceRNA networks offer potential treatments for skin aging and wound healing.

HIF-1α is important for hair growth and could be a treatment target for hair loss.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.